<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did ENTO's operating expenses trend in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 08:22pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Entero Therapeutics' operating expenses for Q4 2024 are not currently available.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_){return {layout:"default",data:[{noData:b,currentQuestion:d,textDescription:r,comeFrom:"AInvestShareLink",events:[],answerSource:h}],fetch:{},error:i,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:h,cache_builder:a,reply_action:"Answer",execute_mode:v,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did ENTO's operating expenses trend in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did ENTO's operating expenses trend in Q4 2024?\",\"user_id\":\"dp86102876\",\"user_name\":\"\",\"trace_id\":\"a20c6db5-53a2-41cf-9c4f-b4c3c280d39a\",\"session_id\":\"a20c6db5-53a2-41cf-9c4f-b4c3c280d39a\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[],answer_chain_name:B,agent_mode:C,native_answer:a,come_from:a,text_answer:r,trace_id:e,cost:10522,event_names:a,question:d,fallback_type:D,input_type:E,fall_back_reason:{fall_back_type:D,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:e,first_return_cost:2085,cache_type:"no_cache",question_id:e,transfer_question:d,signal_type:"ON_COMPLETE",start_time:w,remote_svc:h,slots:[],answer_type:v,user_id:s,skill_name:x},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:e,session_id:e,user_id:s,question:d,source:h,raw_question:d,version:"3.4.1",action_name:x,nlu:{entity:[{type:F,value:"ENTO.O",market:G}]},output_time:w,deep_research:b,deep_thinking:b,agent_mode:C},extra:{}},{answer_path:j,section:{id:k,info_texts:["Thinking"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"begin"},logs:[],extra:{is_deep_research:b,deep_thinking:b}},{answer_path:j,section:{id:k,info_texts:["Querying Stock: ENTO Operating Expenses in Q4 2024"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:c,status:H},logs:[],extra:{action:"Querying Stock",action_input:"ENTO Operating Expenses in Q4 2024",thought:"The user seeks to analyze ENTO's Q4 2024 operating expenses. I should focus on ENTO's Q4 2024 operating expense data. I will use FinQuery for the data mentioned above."}},{answer_path:m,section:{id:y,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Searching Web: Entero Therapeutics Operating Expenses Q4 2024"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:c,status:H},logs:[],extra:{action:"Searching Web",action_input:"Entero Therapeutics Operating Expenses Q4 2024",thought:"I am unable to obtain ENTO's Q4 2024 operating expenses using FinQuery, now I will try again using Search."}},{answer_path:m,section:{id:y,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:m,section:{id:y,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Generating Answer"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"ongoing"},logs:[],extra:{}},{answer_path:m,section:{id:I,info_texts:[],show_type:"rich_text",voice_txt:"En",text_answer:r,rich_text:r,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:m,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"ENTO",market_id:G,name:J,domain:F},pos:f,section_id:I,txt:J,jump_type:"pos_fenshi"}],is_last:c},logs:[],extra:{}},{answer_path:j,section:{id:k,info_texts:["Completed"],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:n,query_text:n,trace_info:{item_id:"0db0f0c5b5a3cdc3aff0b74fcf582955",item_type:g,item_name:n,rec_info:K}},{display_text:o,query_text:o,trace_info:{item_id:"f93c1762bda9aeb241e2b5dd3755b8a5",item_type:g,item_name:o,rec_info:L}},{display_text:p,query_text:p,trace_info:{item_id:"39d17d6b7b1146365e32b05d45bcd845",item_type:g,item_name:p,rec_info:M}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:b,txt_style:f,type:"1",display2:b,url:a}},request_config:[{source_type:N,related_name:O}],puuid:z,tag:a,category:"custom",uuid:P}],global:{urp_static_data:[{name:O,value:{status_code:f,columns:[{type:q,index_name:Q,key:Q},{type:q,index_name:R,key:R},{type:q,index_name:S,key:S},{type:q,index_name:T,key:T},{type:q,index_name:U,key:U}],datas:[{send_text:n,item_type:g,rec_info:K,display_text:n,rec_reason:a},{send_text:o,item_type:g,rec_info:L,display_text:o,rec_reason:a},{send_text:p,item_type:g,rec_info:M,display_text:p,rec_reason:a}],dataSize:N,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:9999,label:V,type:"thslc\u002Fthslc-common-container",leaf:b,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:c,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:u,"min-height":"100%",position:W,height:u},isMaterial:b,id:V,needTheme:b,hasEditor:b,packed:b,events:[],child:[{readmeUrl:"https:",stack:b,visible:c,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:c,version:"1.12.0",animate:[],url:A,componentUuid:P,script:[{name:X,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:c,renderType:"blue"},path:A,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:A},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:u,position:W,height:u},isMaterial:c,_id:19,id:X,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:Y,voice_txt:a,tracking_info:{},uuid:z},order:{is_auto:b,render_for:Y,chart_type:"command",puuid:z}},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{action_name:x,with_paid_index:b,no_refresh_answer:b,answer_source:{agent_id:a,agent_name:a,execute_mode:v,answer_chain_name:B},is_deep_research:b,deep_thinking:b,create_time:1746706972774},is_last:c}],questionItem:{data:{qStr:d,encodeFlag:b,imageData:i,docsData:[],quoteData:i},tplType:"question"},events:Z,agentId:a,param:{entity_info:{},add_info:{ori_question:d},event_list:Z,client_ip:a,question:d,user_id:s,user_name:a,trace_id:e,session_id:e,source:h,input_type:E}}],userId:s,userName:a,startTime:w,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:i,endSignal:b,theme:"white",showTracePopup:b,traceListData:[],chatTraceTargetIndex:f,traceTableData:i,showMask:b}},serverRendered:c,routePath:"\u002Faime\u002Fshare\u002Fhow-did-entos-operating-expenses-trend-in-q4-2024-775936\u002F",config:{_app:{basePath:_,assetsPath:_,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",false,true,"How did ENTO's operating expenses trend in Q4 2024?","a20c6db5-53a2-41cf-9c4f-b4c3c280d39a",0,"llm_generated","ths_ainvest_lite_web",null,"progress\u002Fsearching_for",1000,"searching_for","other\u002FopenAnswer","How do analysts view ENTO's operating expense management in their latest reports?","What was ENTO's total operating expense in Q4 2024?","What percentage of ENTO's revenue were operating expenses in Q4 2024?","STR","Entero Therapeutics' operating expenses for Q4 2024 are not currently available.","dp86102876","signal","auto","agent",1746706962252,"review stocks",999,"39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","186","thinking",2001,"Entero Therapeutics","2+679_496_21_554+0+0+a20c6db5-53a2-41cf-9c4f-b4c3c280d39a+0db0f0c5b5a3cdc3aff0b74fcf582955+llm_generated+aimeTagAnalysis+0+0.009319473057985306+1","2+679_496_21_554+0+0+a20c6db5-53a2-41cf-9c4f-b4c3c280d39a+f93c1762bda9aeb241e2b5dd3755b8a5+llm_generated+aimeTagAnalysis+0+0.005475534126162529+2","2+679_496_21_554+0+0+a20c6db5-53a2-41cf-9c4f-b4c3c280d39a+39d17d6b7b1146365e32b05d45bcd845+llm_generated+aimeTagAnalysis+0+0.0032774205319583416+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>